List of Tables
Table 1. Global Circulating Tumor Cell Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Circulating Tumor Cell Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Circulating Tumor Cell Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Circulating Tumor Cell Kit Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Circulating Tumor Cell Kit Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Circulating Tumor Cell Kit Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Circulating Tumor Cell Kit Sales by Region (2020-2025) & (K Units)
Table 8. Global Circulating Tumor Cell Kit Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Circulating Tumor Cell Kit Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Circulating Tumor Cell Kit Sales Share by Manufacturers (2020-2025)
Table 12. Global Circulating Tumor Cell Kit Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Circulating Tumor Cell Kit Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Circulating Tumor Cell Kit by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell Kit as of 2024)
Table 16. Global Circulating Tumor Cell Kit Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Circulating Tumor Cell Kit Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Circulating Tumor Cell Kit Manufacturing Base and Headquarters
Table 19. Global Circulating Tumor Cell Kit Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Circulating Tumor Cell Kit Sales by Type (2020-2025) & (K Units)
Table 23. Global Circulating Tumor Cell Kit Sales by Type (2026-2031) & (K Units)
Table 24. Global Circulating Tumor Cell Kit Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Circulating Tumor Cell Kit Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Circulating Tumor Cell Kit ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Circulating Tumor Cell Kit Sales by Application (2020-2025) & (K Units)
Table 29. Global Circulating Tumor Cell Kit Sales by Application (2026-2031) & (K Units)
Table 30. Circulating Tumor Cell Kit High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Circulating Tumor Cell Kit Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Circulating Tumor Cell Kit Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Circulating Tumor Cell Kit ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Circulating Tumor Cell Kit Growth Accelerators and Market Barriers
Table 37. North America Circulating Tumor Cell Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Circulating Tumor Cell Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Circulating Tumor Cell Kit Growth Accelerators and Market Barriers
Table 40. Europe Circulating Tumor Cell Kit Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Circulating Tumor Cell Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Circulating Tumor Cell Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Circulating Tumor Cell Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Circulating Tumor Cell Kit Growth Accelerators and Market Barriers
Table 45. Southeast Asia Circulating Tumor Cell Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Circulating Tumor Cell Kit Investment Opportunities and Key Challenges
Table 47. Central and South America Circulating Tumor Cell Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Circulating Tumor Cell Kit Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Circulating Tumor Cell Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Menarini Silicon Biosystems Corporation Information
Table 51. Menarini Silicon Biosystems Description and Major Businesses
Table 52. Menarini Silicon Biosystems Product Models, Descriptions and Specifications
Table 53. Menarini Silicon Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Menarini Silicon Biosystems Sales Value Proportion by Product in 2024
Table 55. Menarini Silicon Biosystems Sales Value Proportion by Application in 2024
Table 56. Menarini Silicon Biosystems Sales Value Proportion by Geographic Area in 2024
Table 57. Menarini Silicon Biosystems Circulating Tumor Cell Kit SWOT Analysis
Table 58. Menarini Silicon Biosystems Recent Developments
Table 59. Qiagen Corporation Information
Table 60. Qiagen Description and Major Businesses
Table 61. Qiagen Product Models, Descriptions and Specifications
Table 62. Qiagen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Qiagen Sales Value Proportion by Product in 2024
Table 64. Qiagen Sales Value Proportion by Application in 2024
Table 65. Qiagen Sales Value Proportion by Geographic Area in 2024
Table 66. Qiagen Circulating Tumor Cell Kit SWOT Analysis
Table 67. Qiagen Recent Developments
Table 68. STEMCELL Technologies Corporation Information
Table 69. STEMCELL Technologies Description and Major Businesses
Table 70. STEMCELL Technologies Product Models, Descriptions and Specifications
Table 71. STEMCELL Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. STEMCELL Technologies Sales Value Proportion by Product in 2024
Table 73. STEMCELL Technologies Sales Value Proportion by Application in 2024
Table 74. STEMCELL Technologies Sales Value Proportion by Geographic Area in 2024
Table 75. STEMCELL Technologies Circulating Tumor Cell Kit SWOT Analysis
Table 76. STEMCELL Technologies Recent Developments
Table 77. ScreenCell Corporation Information
Table 78. ScreenCell Description and Major Businesses
Table 79. ScreenCell Product Models, Descriptions and Specifications
Table 80. ScreenCell Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. ScreenCell Sales Value Proportion by Product in 2024
Table 82. ScreenCell Sales Value Proportion by Application in 2024
Table 83. ScreenCell Sales Value Proportion by Geographic Area in 2024
Table 84. ScreenCell Circulating Tumor Cell Kit SWOT Analysis
Table 85. ScreenCell Recent Developments
Table 86. Fluxion Biosciences Corporation Information
Table 87. Fluxion Biosciences Description and Major Businesses
Table 88. Fluxion Biosciences Product Models, Descriptions and Specifications
Table 89. Fluxion Biosciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Fluxion Biosciences Sales Value Proportion by Product in 2024
Table 91. Fluxion Biosciences Sales Value Proportion by Application in 2024
Table 92. Fluxion Biosciences Sales Value Proportion by Geographic Area in 2024
Table 93. Fluxion Biosciences Circulating Tumor Cell Kit SWOT Analysis
Table 94. Fluxion Biosciences Recent Developments
Table 95. Biocept Corporation Information
Table 96. Biocept Description and Major Businesses
Table 97. Biocept Product Models, Descriptions and Specifications
Table 98. Biocept Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Biocept Recent Developments
Table 100. pluriSelect Corporation Information
Table 101. pluriSelect Description and Major Businesses
Table 102. pluriSelect Product Models, Descriptions and Specifications
Table 103. pluriSelect Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. pluriSelect Recent Developments
Table 105. Roche Corporation Information
Table 106. Roche Description and Major Businesses
Table 107. Roche Product Models, Descriptions and Specifications
Table 108. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Roche Recent Developments
Table 110. Hangzhou Watson Biotech Corporation Information
Table 111. Hangzhou Watson Biotech Description and Major Businesses
Table 112. Hangzhou Watson Biotech Product Models, Descriptions and Specifications
Table 113. Hangzhou Watson Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Hangzhou Watson Biotech Recent Developments
Table 115. Key Raw Materials Distribution
Table 116. Raw Materials Key Suppliers
Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 118. Milestones in Production Technology Evolution
Table 119. Distributors List
Table 120. Market Trends and Market Evolution
Table 121. Market Drivers and Opportunities
Table 122. Market Challenges, Risks, and Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Circulating Tumor Cell Kit Product Picture
Figure 2. Global Circulating Tumor Cell Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. IVD Product Picture
Figure 4. RUO Product Picture
Figure 5. Global Circulating Tumor Cell Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Breast Cancer
Figure 7. Prostate Cancer
Figure 8. Colorectal Cancer
Figure 9. Lung Cancer
Figure 10. Others
Figure 11. Circulating Tumor Cell Kit Report Years Considered
Figure 12. Global Circulating Tumor Cell Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 14. Global Circulating Tumor Cell Kit Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Circulating Tumor Cell Kit Revenue Market Share by Region (2020-2031)
Figure 16. Global Circulating Tumor Cell Kit Sales (2020-2031) & (K Units)
Figure 17. Global Circulating Tumor Cell Kit Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Circulating Tumor Cell Kit Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Circulating Tumor Cell Kit Sales Volume Market Share in 2024
Figure 20. Global Circulating Tumor Cell Kit Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. IVD Revenue Market Share by Manufacturer in 2024
Figure 23. RUO Revenue Market Share by Manufacturer in 2024
Figure 24. Global Circulating Tumor Cell Kit Sales Market Share by Type (2020-2031)
Figure 25. Global Circulating Tumor Cell Kit Revenue Market Share by Type (2020-2031)
Figure 26. Global Circulating Tumor Cell Kit Sales Market Share by Application (2020-2031)
Figure 27. Global Circulating Tumor Cell Kit Revenue Market Share by Application (2020-2031)
Figure 28. North America Circulating Tumor Cell Kit Sales YoY (2020-2031) & (K Units)
Figure 29. North America Circulating Tumor Cell Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Circulating Tumor Cell Kit Sales Revenue (US$ Million) in 2024
Figure 31. North America Circulating Tumor Cell Kit Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Circulating Tumor Cell Kit Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Circulating Tumor Cell Kit Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Circulating Tumor Cell Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Circulating Tumor Cell Kit Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Circulating Tumor Cell Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Circulating Tumor Cell Kit Sales Revenue (US$ Million) in 2024
Figure 41. Europe Circulating Tumor Cell Kit Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Circulating Tumor Cell Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Circulating Tumor Cell Kit Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Circulating Tumor Cell Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 46. France Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Circulating Tumor Cell Kit Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Circulating Tumor Cell Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Circulating Tumor Cell Kit Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Circulating Tumor Cell Kit Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Circulating Tumor Cell Kit Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Circulating Tumor Cell Kit Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Circulating Tumor Cell Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 61. India Circulating Tumor Cell Kit Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Circulating Tumor Cell Kit Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Circulating Tumor Cell Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Circulating Tumor Cell Kit Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Circulating Tumor Cell Kit Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Circulating Tumor Cell Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Circulating Tumor Cell Kit Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Circulating Tumor Cell Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Circulating Tumor Cell Kit Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Circulating Tumor Cell Kit Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Circulating Tumor Cell Kit Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Circulating Tumor Cell Kit Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Circulating Tumor Cell Kit Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Circulating Tumor Cell Kit Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Circulating Tumor Cell Kit Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Circulating Tumor Cell Kit Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Circulating Tumor Cell Kit Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Circulating Tumor Cell Kit Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Circulating Tumor Cell Kit Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Circulating Tumor Cell Kit Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Circulating Tumor Cell Kit Revenue (2020-2025) & (US$ Million)
Figure 82. Circulating Tumor Cell Kit Industry Chain Mapping
Figure 83. Regional Circulating Tumor Cell Kit Manufacturing Base Distribution (%)
Figure 84. Global Circulating Tumor Cell Kit Production Market Share by Region (2020-2031)
Figure 85. Circulating Tumor Cell Kit Production Process
Figure 86. Regional Circulating Tumor Cell Kit Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
